NICHD - News Releases

All News releases related to the Pediatric

Your search for: All Related News Releases All Years returned the following 15 results:

06/04/08		Findings Offer Insights into Role of Breastfeeding in Preventing Infant Death, HIV Infection in Resource Poor Countries
In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk—or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy. Now, two studies supported by the National Institutes of Health offer insights into preventing early death and HIV infection among breastfeeding infants of mothers with HIV in these countries.

02/06/08		Item of Interest: Extended Nevirapine Regimens Reduce HIV Transmission and Death in Breastfed Infants of HIV-infected Mothers
An extended course of the antiretroviral drug nevirapine (NVP) helps the breastfeeding babies of HIV-infected mothers remain HIV-negative and live longer, according to several new studies presented at the 15th Conference on Retroviruses and Opportunistic Infections held in Boston from February 3–6.

02/06/08		Item of Interest: The Post-Exposure Prophylaxis of Infant (PEPI)-Malawi Study Sponsored by NICHD and CDC
Questions and Answers

06/11/07		Public Comment: DRAFT Pediatric, Adolescent, and Maternal AIDS Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act.

01/10/07		Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive Regimen
A woman's response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.)

12/07/06		Hormonal Contraception Does Not Appear To Increase HIV Risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

07/09/04		Thai Study Shows That Inexpensive Treatment Reduces Risk Of Mother To Child HIV Transmission
A single dose of the drug nevirapine given at the beginning of labor, when combined with a short course of the anti-HIV drug AZT (zidovudine), dramatically reduces a woman's chances of passing HIV on to her child, according to a study of Thai women funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

06/30/04		Multivitamins During Pregnancy and After Birth Delay Progression of HIV In Women
Multivitamin supplements containing high doses of the vitamin B complex, as well as vitamins C and E, given to HIV-infected women during pregnancy and for more than 5 years after they gave birth reduced the symptoms of AIDS, according to a study of Tanzanian women supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the John E. Fogarty International Center (FIC) for Advanced Study in the Health Sciences, both of the National Institutes of Health. The supplements also bolstered counts of disease-fighting immune cells, and modestly lowered HIV levels in the blood.

06/16/04		Analysis Shows Infants of Mothers Infected With HIV Face Nearly Constant Risk For HIV Infection For Duration of Breastfeeding
After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed, according to an analysis conducted and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. Previously, researchers thought the risk for being infected with the virus from breast milk diminished as an infant grew older.

06/12/02		Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks
A new study found no association between the use of an anti-HIV treatment that uses a combination of drugs during pregnancy and an increased risk of such birth complications as premature delivery, stillbirth, and low Apgar scores.

07/27/01		NICHD Funds New Sites To Follow Disease Progression In HIV-Infected Women
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will fund three sites to conduct research to increase understanding of how infection with the human immunodeficiency virus (HIV) affects adolescent and adult women.

10/04/00		Shorter AZT Treatment Reduces Mother to Child HIV Transmission as Well as Longer Treatment but for Less Cost
A shorter course of AZT therapy than currently prescribed for HIV-infected pregnant women may allow women in developing countries to afford the treatment that can reduce their babies' chances of contracting AIDS, but at a much lower cost, according to a study in the October 5 New England Journal of Medicine.

08/04/99		High HIV RNA Levels Major Risk Factor for Mother-to-Child HIV Transmission
Two studies supported by the National Institutes of Health (NIH) provide compelling evidence that the amount of HIV in a pregnant woman's blood, known as the maternal HIV viral load, is the prime risk factor for transmitting the virus to her baby.

01/28/99		C-Sections Before Labor and Rupture of Membranes Reduce the Risk of Maternal-Infant HIV Transmission by Half (update)
The largest, most comprehensive analysis of its kind has found that pregnant women infected with HIV can reduce the risk of transmitting the virus to their infants by about 50 percent if they deliver by elective cesarean section--before they have gone into labor and before their membranes have ruptured, according to a study led by a researcher at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

06/27/98		C-Sections Before Labor and Rupture of Membranes Reduce the Risk of Maternal-Infant HIV Transmission by Half
The largest, most comprehensive analysis of its kind has found pregnant women infected with HIV can reduce the risk of transmitting the virus to their infants by about 50 percent if they deliver by elective cesarean section--before they have gone into labor and before their membranes have ruptured, according to a study led by a researcher at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.